Verition Fund Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
Verition Fund Management's ABVX Position: Q3 2026 in Review
Verition Fund Management increased its Abivax (ABVX) stake by 173% in Q3 2026, buying an estimated $22.1M and bringing the position to 289,336 shares worth $28.7M. The position accounts for 0.16% of the portfolio, ranked #110.
Verition Fund Management first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. 317 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Verition Fund Management held 289,336 shares of Abivax worth $28.7M as of Q3 2026.
- Verition Fund Management bought 183,545 Abivax shares in Q3 2026, an estimated $22.1M.
- Abivax made up 0.16% of Verition Fund Management's portfolio in Q3 2026, its #110 holding.
- Verition Fund Management first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
- 317 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.